Back to Journals » Vascular Health and Risk Management » Volume 2 » Issue 2
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1509)
- Volume 20, 2024 (13)
- Volume 19, 2023 (86)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 2, 2006
Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program
Martin Claridge, Simon Hobbs, Clive Quick, Donald Adam, Andrew Bradbury, Teun Wilmink
Vascular Health and Risk Management 2006, 2:189-191
Published Date: 15 June 2006
Vascular risks and management of obesity in children and adolescents
Courtney J Jolliffe, Ian Janssen
Vascular Health and Risk Management 2006, 2:171-187
Published Date: 15 June 2006
Leptin and hypertension in obesity
Paco E Bravo, Stephen Morse, David M Borne, Erwin A Aguilar, Efrain Reisin
Vascular Health and Risk Management 2006, 2:163-169
Published Date: 15 June 2006
Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence
Craig S Patch, Linda C Tapsell, Peter G Williams, Michelle Gordon
Vascular Health and Risk Management 2006, 2:157-162
Published Date: 15 June 2006
Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction
Krishnankutty Sudhir
Vascular Health and Risk Management 2006, 2:153-156
Published Date: 15 June 2006
Metabolic syndrome, inflammation and atherosclerosis
Rodolfo Paoletti, Chiara Bolego, Andrea Poli, Andrea Cignarella
Vascular Health and Risk Management 2006, 2:145-152
Published Date: 15 June 2006
The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J Materson
Vascular Health and Risk Management 2006, 2:139-144
Published Date: 15 June 2006
Valsartan in the treatment of heart attack survivors
Bodh I Jugdutt
Vascular Health and Risk Management 2006, 2:125-138
Published Date: 15 June 2006
A review of Perindopril in the reduction of cardiovascular events
Duncan J Campbell
Vascular Health and Risk Management 2006, 2:117-124
Published Date: 15 June 2006
Endovascular stent-graft placement for vascular failure of the thoracic aorta
Yoshihiko Kurimoto, Kiyofumi Morishita, Yasufumi Asai
Vascular Health and Risk Management 2006, 2:109-116
Published Date: 15 June 2006
Clinical implications of angiogenesis in cancers
Roberta WC Pang, Ronnie TP Poon
Vascular Health and Risk Management 2006, 2:97-108
Published Date: 15 June 2006
Editorial: Risk of cardiovascular events and cyclooxygenase-2 inhibitors ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2006, 2:95-96
Published Date: 15 June 2006